Prognostic parameters and risk stratification in intensive care patients with severe liver diseases

Journal of Gastrointestinal and Liver Diseases

Volumn 19, Issue 4, 2010, Pages 399-404

  Lehner, Sebastian ^a   Stemmler, Hans Joachim ^b   Mück, Alexander ^b   Braess, Jan ^b   Parhofer, Klaus G ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Child Pugh score; Glasgow Coma Scale; ICU admission; Liver failure; MELD score; Prognostic parameters; Risk stratification

Indexed keywords

BILIRUBIN; CATECHOLAMINE; CREATININE; BIOLOGICAL MARKER;

ACUTE LIVER FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD POUGH SCORE; CHRONIC LIVER FAILURE; CREATININE BLOOD LEVEL; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MODEL OF END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; PROGNOSIS; SCORING SYSTEM; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; SURVIVOR; BLOOD; CHI SQUARE DISTRIBUTION; END STAGE LIVER DISEASE; GERMANY; HOSPITALIZATION; INTENSIVE CARE; MICTURITION; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SURVIVAL; SURVIVAL RATE; TIME;

ADULT; BILIRUBIN; BIOLOGICAL MARKERS; CATECHOLAMINES; CHI-SQUARE DISTRIBUTION; CREATININE; END STAGE LIVER DISEASE; FEMALE; GERMANY; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; LIVER FAILURE, ACUTE; LOGISTIC MODELS; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; URINATION;

EID: 79955687999     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Blaker H, Theuer D, Otto HF. Pathology of liver cirrhosis and portal hypertension. Radiologe 2001; 41: 833-839.
2. Herrmann T, Smolarek C, Gehrke S, Schafer M, Stremmel W. Hemochromatosis and Wilson disease. Internist (Berl) 1999; 40: 513-521.
3. Robert Koch Institute. Virushepatitis B, C und D im Jahr 2008. Epid Bull 2009; 20.
4. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526.
5. World Health Organisation DoMSA. Global Status Report on Alcohol 2004. Genf. 2004.
6. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101 Suppl 1: S1-6.
7. Zhou H, Fischer HP. Hereditary hemochromatosis, alpha-1-antitrypsin deficiency and Wilson's disease. Pathogenesis, clinical findings and pathways to diagnosis. Pathologe 2008; 29: 73-83.
8. Goldberg E, Chopra S. Overview of the complications, prognosis, and management of cirrhosis. UpToDate 2009.
9. Goldberg E, Chopra S. Diagnostic Approach to the Patient with Cirrhosis. UpToDate 2009.
10. Huber M, Schwarz W, Vogl T, Zeuzem S. Klinik der Leberzirrhose und ihrer Komplikationen sowie diagnostische Fragestellungen. Radiologe 2001; 41: 840-851.
11. Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA. Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 1996; 23: 1393-1401.
12. Cholongitas E, Senzolo M, Patch D, et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006; 23: 883-893.
13. Mackle IJ, Swann DG, Cook B. One year outcome of intensive care patients with decompensated alcoholic liver disease. Br J Anaesth 2006; 97: 496-498.
14. Chatzicostas C, Roussomoustakaki M, Notas G, et al. A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosis. BMC Gastroenterol 2003; 3: 7.
15. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85.
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
17. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
18. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
19. Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care 2008; 14: 189-197.
20. Lecleire S, Di Fiore F, Merle V, et al. Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol 2005; 39: 321-327.
21. Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005; 54: 718-725.
22. Lane A, Baggot M, Power M, Dwyer R. Benchmarking outcome in ICU. Ir Med J 2005; 98: 213-215.
23. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? J Hepatol 2004; 41: 344-350.
24. Tome S, Martinez-Rey C, Gonzalez-Quintela A, et al. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol 2002; 36: 793-798.
25. Choi PC, Kim HJ, Choi WH, et al. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver Int 2009; 29: 221-226.
26. Chen SC, Huang CC, Tsai SJ, et al. Severity of disease as main predictor for mortality in patients with pyogenic liver abscess. Am J Surg 2009; 198: 164-172.
27. Bastos PG, Sun X, Wagner DP, Wu AW, Knaus WA. Glasgow Coma Scale score in the evaluation of outcome in the intensive care unit: findings from the Acute Physiology and Chronic Health Evaluation III study. Crit Care Med 1993; 21: 1459-1465.
28. Kaplan M. Clinical aspects of serum bilirubin determination. UpToDate 2009.
29. Bambha KM, Biggins SW. Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions. Curr Opin Organ Transplant 2008; 13: 227-233.
30. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41: 1282-1289.
31. Carl DE, Sanyal A. The management of hepatorenal syndrome. Minerva Gastroenterol Dietol 2009; 55: 207-226.
32. McCormick PA, Donnelly C. Management of hepatorenal syndrome. Pharmacol Ther 2008; 119: 1-6.
33. Cassinello C, Moreno E, Gozalo A, Ortuno B, Cuenca B, Solis-Herruzo JA. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci 2003; 48: 179-186.
34. Serra MA, Puchades MJ, Rodriguez F, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scand J Gastroenterol 2004; 39: 1149-1153.
35. Gooneratne N, Manaker S. Use of vasopressors and inotropes. UpToDate 2009.
36. Jenkins CR, Gomersall CD, Leung P, Joynt GM. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesth Intensive Care 2009; 37: 286-289.
37. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677-685.
38. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-48.
39. Mathurin S, Chapelet A, Spanevello V, et al. [Infections in hospitalized patients with cirrhosis. Medicina (B Aires) 2009; 69: 229-238.
40. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
41. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23: 73-98.
42. Cheong HS, Kang CI, Lee JA, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009; 48: 1230-1236.
43. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174.
44. Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010 Jun 14 (Epub ahead of print).